glp-1 drugs and dementia Microdosing, Brain Health & Alzheimer's Prevention Transformation 2.0: The GLP-1 RAs
Description
5 Safety, clinical tolerability, and periconception management strategies From the perspective of actionable clinical management, this section categorizes three core challenges associated with the use of GLP-1RAs in women of reproductive age with PCOS: (i) discontinuity in adherence driven by gastrointestinal adverse effects
doi: 10.1111/bjd.12886 42 MoensEVeldhoenM
reported that liraglutide and exendin-4, respectively, attenuated self-administration and reinstatement in these rodents, while repeated administration of GLP-1RAs reduced the occurrence of withdrawal-induced hyperphagia and post-smoking cessation weight gain [20, 21]
End-capped -helices as modulators of protein function
